and concomitant medication data [number of glucose-lowering agents, total daily insulin dose, and use of sodium/glucose cotransporter 2 (SGLT-2) inhibitors, insulin, or biguanides]
Starting conversations with your provider should include discussion of your weight-loss history, metabolic markers, family history of obesity or diabetes, and any prior experience with medications that affect appetite or mood
Ethical approval and consent to participate The study protocol was approved by the Institutional Review Board (IRB) of the Fifth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China (Approval No: K287-1
A549 cells and the fetal hepatocyte cell line L-O2 were treated with the following inhibitors for 24 hr: L-mimosine (G1), aphidicolin (S), nocodazole (G2), and colchicine (M)